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QUANTITATIVE HISTOCHEMISTRY OF THE PRIMATE SKIN
VII. PYRUVATE KINASE*
KENJI ADACHI, M.D., PH.D. AND SHOKO YAMASAWA, B.Sc.
The principal metabolic reaction catalyzed by
pyruvate kinase is the transfer of a phosphoryl
group from phosphoenolpyruvate (PEP) to
adenosine diphosphate (ADP), yielding pyru-
vate and adenosine triphosphate (ATP). The
significance of this reaction is the synthesis of
ATP, the most essential substance in energy me-
tabolism in all living matter.
Although the presence of pyruvate kinase has
been demonstrated in 19 different tissues from
11 species of animals ranging from protozoa to
mammals (1), there is practically no informa-
tion on this kinase in skin. Bernstein and Sweet
(2) have shown that PEP is stoichiometrically
converted to lactic acid by extracts of skin of
young rats.
In this communication we report the presence
of highly active pyruvate kinase in the skin of
primates as well as the results of a study of
some catalytic characteristics of this kinase in
epidermal homogenate of the rhesus monkey.
MATERIALS AN METHODs
The preparation of samples of primate skin
has been described in a previous paper (3). The
assay of pyruvate kinase is based on the measure-
ment of this kinase reaction product, pyruvate,
since fluorometric determination of pyruvate is
applicable in a NADH'-coupled reaction with
crystalline lactate dehydrogenase added as auxil-
iary enzyme. The complete assay reagents2 con-
sisted of 4 mM PEP; 2 mM AD?; 5 mM MgSO4;
50 mM KCI; 1 mM NADH; 5 jzg/ml reagent
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Abbreviations used are: NADH and NAD
nicotinamide adenine dinucleotide, reduced and
oxidized forms, respectively; PEP = phosphoenol-
pyruvate; ADP adenosine diphosphate; ATP =
adenosine triphosphate; LDH = lactate dehydro-
genase.
chemicals were commercially available and
of reagent grade. The crystalline lactate dehydro-
genase had a specific activity of 400 moIes of py-
ruvate to lactate per minute per mg protein at pH
7.5 at 37° C.
mixture LDH; 0.05% bovine plasma albumin;
0.1 M imidazole buffer, pH 7.0; and 5 d of the
epidermal homogenate (0.1 to 025%) in a total
volume of 50 id. After incubation at 37° C for 30
minutes, the NAD formed was measured as al-
ready described (4).
The distribution of pyruvate kinase in various
parts of the skin was estimated by incubating
0.5 to 5 eg samples in 18 id of the reagent mixture
for 30 minutes at 37° C and then measuring the
resulting NAD as also described previously (4).
A stock NADH solution was prepared fresh each
week to minimize blank values.
ATP concentration was measured according to
the method described by Lowry et at. (5), lactate
concentration, according to the method of Barker
and Summerson (6), and PEP substrate concen-
tration, with the method described by Lowry et
at. (5) and by Bücher (7).
RESULTS
The pH activity curve is shown in Fig. 1.
Pyruvate kinase is one of a few enzymes which
has its optimal pH within physiological pH
range (7.0—7.3). It appears that Tris buffer is
slightly inhibitory to the enzyme activity. Fig-
ure 2 shows the effect of substrate (PEP) con-
centration. The optimal concentration of PEP
ranged from 4 mM to 8 mM. The apparent
Michaelis constant for PEP was 6.7 x 10 M;
the value coincided with the Km 7 to 8 x 10
M for rabbit muscle pyruvate kinase (1). The
result of a typical experiment on the effect of
AD? concentration is shown in Fig. 3. The op-
timal ADP concentration was attained between
2 and 4 mM, but 7.6 mM ADP had a remark-
able substrate inhibition. A graphical analysis of
Km for ADP resulted, 1.5 x 10° M, which was
at the same order of magnitude as the Km for
rabbit muscle enzyme (2 to 3 X 10 M).
The effect of magnesium ion concentration
was also tested. As shown in Fig. 4, Mg is
nearly an absolute requirement for pyruvate
kinase reaction. Enzyme activity was propor-
tionally increased with Mg (up to 2.5 mM)
and reached the optimal concentration between
5 and 10 mM. The addition of K was also
found to be essential for this kinase reaction
(Fig. 5). The final K concentration between 50
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Fia. 1. pH activity curve. For detailed assay
conditions, see text. The ordinate indicates the
enzyme activity expressed as the microammeter
reading due to fluorescence.
0 2 4 6
ADP mM
Fia. 3. Effect of ADP concentration. The reac-
tion mixture as in the text with different ADP
levels.
Fm. 4. Effect of Mg concentration. Test sys-
tem as in the text with different concentrations of
MgSO4.
Fm. 5. Effect of K concentration. Assay system
as in the text. The source of K was KC1.
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NADH mM
Fia. 6. Effect of NADH concentration. A similar
curve was obtained in studying the effect of
NADH for epidermal lactate dehydrogenase (8).
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pyruvate kinase described above depends on the
auxiliary LDH system, the effects of LDH and
NADH concentrations were also tested mdi-.
80
60
a,UC
a,U
0,
a,
0
=
U- 20
0
40
30
20
I0
Mg SO4 mM
a,UC
a,U0
a,
0
U-
•1
40
PEP 4mM
—PEP mM
a,UC
a,
a,
000 2 4 6
PEP mM
Fia. 2. Effect of PEP concentration. The test
system as in the text except for varying amount of
PEP.
80
a,
60
a,
U
40
20
KC1. mM
PYRUVATE KINASE ACTIVITY IN THE PRIMATE SKIN 291
vidually. The omission of crystalline LDH from
the reagent mixture caused only a 5 to 15%
lower activity than the full pyruvate kinase
activity. This indicates the presence of a con-
siderable amount of endogenous LDII in epi-
dermal homogenate. As shown in Fig. 6, 0.5 to 1
mM of NADH are necessary to obtain optimal
activity.
Under the optimal assay condition described
above, a linear rate of pyruvate kinase reaction
was assessed up to 20 mjmoles of NAD pro-
duction per tube (Fig. 7). This reaction pro-
ceeds stoichiometrically with the epidermal
homogenate as enzyme source, i.e., the consump-
tion of PEP (55 mmoles) and NADH (53
mmoles) corresponds well to synthesis of ATP
(55 mmoles), lactic acid (57 mmoles), and
NAD (55 mmoles). This clearly validates the
assay method for skin pyruvate kinase.
Table I is a summary of the results of a quan-
titative histochemical study of pyruvate kinase
activities in various parts of primate skin. Ex-
cept for mucous membranes, the distribution
pattern of pyruvate kinase activity is similar in
the rhesus monkey and stump-tail macaque. Ex-
cept for the keratin layer, pyruvate kinase is
generally abundant through the epidermis and in
all of the appendages. Enzyme activity in the
epidermis, hair follicles and eccrine sweat
glands was found within a range of 10 to 15
moles/kg dry wt/hr. The sebaceous glands in
the scalp and lips have a relatively low pyru-
vate kinase activity from 4.6 to 6.4 moles/kg
dry wt/hr, and the apoerine sweat glands con-
tain a moderate activity (8.3 moles/kg dry
wt/hr). A minute or insignificant amount of
enzyme activity was associated with the dermis
and keratin layer of the epidermis of the sole.
DISCUSSION
In general, pyruvate kinase appears to be one
of the most active glycolytic enzymes in pri-
mate skin. Its activity in the epidermis of the
scalp, for example, is 20 to 30 times higher than
hexokinase or fructoaldolase activity of the
same region. Among the glycolytic enzymes in
the skin thus far studied, only lactic dehy-
drogenase activity (8) is comparable to this
enzyme. The distribution patterns of these two
enzymes are similar, i.e., both have high activi-
ties (approximately 10 to 20 moles/kg dry
wt/hr) in the epidermis, hair follicles and
Regions Rhmo'
Stump-
maque
SCALP
Epidermis 14.3 11.3
Hair follicle 12.3 14.0
Eccrine gland 10.8 15.3
Apocrine gland — 8.3
Sebaceous gland 4.6 5.6
Dennis 0.7 0.5
SOLE
Keratin layer 0.1 0.8
Granular layer 7.2 5.7
Prickle layer 11.7 13.4
Basal layer 9.7 10.5
Eccrine gland 12.8 9.3
Dermis 0.8 0.1
LIP
Mucous membrane, upper 5.6 16.6
Mucous membrane, lower 7.3 20.4
Sebaceous gland 6.2 6.4
* Pyruvate kinase activity is expressed as
moles of the substrate catalyzed per kilogram
dry weight sample per hour (moles/kg dry wt/hr).
Each figure is the mean of five determinations.
eccrine sweat glands, and relatively low activity
in the sebaceous glands of the scalp (4 to 8
moles/kg dry wt/hr). These data coincide with
the close association of these two enzymes, i.e.,
pyruvate kinase and lactate dehydrogenase suc-
cessively participate in the final steps of the
Embden-Meyerhof glycolytic pathway.
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Fic. 7. Time course and effect of enzyme con-
centration. The assay asystem as described in the
text with different enzyme concentrations as indi-
cated in the figure.
TABLE I
Pyruvae kinase acivi1y of various skin struclures*
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The metabolic role of pyruvate kinase has
been documented as the synthesis of ATP as a
part of glycolysis. Our data suggest an addi-
tional role of this enzyme: the acceleration of
glycolysis and oxidation of the resulting pyru-
vie via the tricarboxylic acid cycle may cause
an elevation of ATP and a lowering of ADP
levels on which this pyruvate kinase is closely
dependent. Hence, a lowering of pyruvate ki-
nase activity would cause an inhibition of gly-
colysis. A similar inhibitory mechanism for
control of glycolysis may exist in glycerate
kinase. It is also noteworthy that this enzyme
is under the control of Mg44 and K4 which are
distributed intra- as well as extracellularly.
Therefore, it is possible that these cations regu-
late, at least in part, glycolysis in primate skin,
although no information concerning the intra-
cellular cation concentrations in skin is avail-
able at present.
SUMMARY
Abundant pyruvate kinase activities were
assayed in samples (averaging 1 jzg) of various
parts of the skin. The epidermis, except for the
keratin and granular layers, the hair follicles
and eccrine sweat glands contained from 10 to
15 moles/kg dry wt/hr of pyruvate kinase
activity. The sebaceous glands have less en-
zyme activities (4.5 to 6.5 moles/kg dry wt/hr)
than the other appendages. Epidermal pyruvate
kinase activity is dependent on Mg and K4,
and the latter ion is an absolute requirement
for the enzyme. A possible physiological role of
this enzyme, in addition to ATP (or energy)
synthesis, might be that of a regulator in the
glycolytic pathway by competing for a common
substrate (ADP) with aerobic ATP synthesis
via tricarboxylic acid cycle.
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